Allyl isothiocyanate exacerbates acute toxoplasmosis through inhibition of inflammatory cytokines
- Author:
Qiu-Mei LIN
1
;
Hong-Bin LONG
;
Jun-Ting HE
;
Zhi-hao ZHANG
;
Ho-Woo NAM
;
Fu-Shi QUAN
;
Qi ZHONG
;
Xu-Qing LIU
;
Zhao-Shou YANG
Author Information
- Publication Type:Brief Communication
- From: Parasites, Hosts and Diseases 2024;62(4):476-483
- CountryRepublic of Korea
- Language:English
- Abstract: Allyl isothiocyanate (AITC) is a natural product commonly used in food preservation and pharmaceutical applications. Toxoplasmosis, caused by the protozoan pathogen Toxoplasma gondii, is prevalent globally while the impact of AITC on toxoplasmosis is unclear. We explored the effect of AITC on acute toxoplasmosis. We infected C57BL/6 mice with T. gondii type I RH strain following AITC administration. On the 4th day after infection, which corresponds to the initial stage of infection, we collected serum for the determination of inflammatory cytokine levels. The mice serum of the AITC-administered group contained significantly lower levels of granulocyte colony-stimulating factor, interferon-gamma, interleukin (IL)-23 subunit p19, IL-4, IL-6, and monocyte chemoattractant protein-1. The lifespan of the mice in the AITC-administered group was significantly reduced. In vitro experiments showed that AITC promoted the proliferation of intracellular T. gondii accompanied by the inhibition of IL-4, IL-1β, and IL-6 production in RAW264.7 macrophages. Our results showed that AITC facilitated T. gondii infection in the early stage by inhibiting the production of several inflammatory cytokines.
